CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 85 filers reported holding CHEMOCENTRYX INC in Q3 2017. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $311,024,000 | +116.2% | 6,020,594 | +3.7% | 0.01% | +125.0% |
| Q2 2022 | $143,878,000 | +12.1% | 5,806,227 | +13.4% | 0.00% | +33.3% |
| Q1 2022 | $128,342,000 | -30.9% | 5,119,315 | +0.4% | 0.00% | -25.0% |
| Q4 2021 | $185,654,000 | +124.2% | 5,098,980 | +5.3% | 0.00% | +100.0% |
| Q3 2021 | $82,816,000 | +27.3% | 4,843,053 | -0.3% | 0.00% | 0.0% |
| Q2 2021 | $65,071,000 | -73.9% | 4,859,704 | -0.2% | 0.00% | -71.4% |
| Q1 2021 | $249,490,000 | -15.1% | 4,869,066 | +2.6% | 0.01% | -22.2% |
| Q4 2020 | $293,963,000 | +17.1% | 4,747,470 | +3.6% | 0.01% | +12.5% |
| Q3 2020 | $251,009,000 | +20.4% | 4,580,467 | +26.4% | 0.01% | +14.3% |
| Q2 2020 | $208,482,000 | +132.7% | 3,623,260 | +62.5% | 0.01% | +75.0% |
| Q1 2020 | $89,592,000 | +8.8% | 2,229,788 | +7.1% | 0.00% | +33.3% |
| Q4 2019 | $82,331,000 | +540.7% | 2,081,682 | +9.8% | 0.00% | – |
| Q3 2019 | $12,850,000 | -22.1% | 1,895,271 | +6.8% | 0.00% | -100.0% |
| Q2 2019 | $16,502,000 | -7.6% | 1,774,489 | +37.9% | 0.00% | 0.0% |
| Q1 2019 | $17,868,000 | +20.4% | 1,286,426 | -5.4% | 0.00% | 0.0% |
| Q4 2018 | $14,842,000 | -11.7% | 1,360,484 | +2.3% | 0.00% | 0.0% |
| Q3 2018 | $16,805,000 | +3.0% | 1,329,494 | +7.3% | 0.00% | 0.0% |
| Q2 2018 | $16,312,000 | -1.9% | 1,238,595 | +1.3% | 0.00% | 0.0% |
| Q1 2018 | $16,623,000 | +125.9% | 1,222,282 | -1.2% | 0.00% | – |
| Q4 2017 | $7,359,000 | -19.5% | 1,236,772 | +0.4% | 0.00% | – |
| Q3 2017 | $9,141,000 | -19.4% | 1,231,990 | +1.6% | 0.00% | -100.0% |
| Q2 2017 | $11,345,000 | +30.0% | 1,212,074 | +1.1% | 0.00% | – |
| Q1 2017 | $8,727,000 | +2.4% | 1,198,730 | +4.1% | 0.00% | – |
| Q4 2016 | $8,519,000 | +26.1% | 1,151,255 | +2.9% | 0.00% | – |
| Q3 2016 | $6,757,000 | +38.9% | 1,118,772 | +3.3% | 0.00% | – |
| Q2 2016 | $4,863,000 | +91.8% | 1,083,075 | +6.4% | 0.00% | – |
| Q1 2016 | $2,535,000 | -67.2% | 1,018,062 | +6.6% | 0.00% | -100.0% |
| Q4 2015 | $7,736,000 | -95.6% | 955,053 | -85.0% | 0.00% | -85.7% |
| Q3 2015 | $175,949,000 | +2370.8% | 6,372,543 | +636.5% | 0.01% | – |
| Q2 2015 | $7,121,000 | +11.1% | 865,193 | +1.9% | 0.00% | – |
| Q1 2015 | $6,408,000 | +13.4% | 848,751 | +2.6% | 0.00% | – |
| Q4 2014 | $5,653,000 | +61.9% | 827,630 | +6.6% | 0.00% | – |
| Q3 2014 | $3,492,000 | -20.2% | 776,025 | +3.8% | 0.00% | – |
| Q2 2014 | $4,375,000 | -10.4% | 747,836 | +1.5% | 0.00% | – |
| Q1 2014 | $4,883,000 | +34.0% | 736,434 | +17.0% | 0.00% | – |
| Q4 2013 | $3,645,000 | +37.6% | 629,486 | +32.1% | 0.00% | – |
| Q3 2013 | $2,649,000 | -60.1% | 476,453 | +1.4% | 0.00% | -100.0% |
| Q2 2013 | $6,644,000 | – | 469,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |